Hydrocodone/aspirin
| Combination of | |
|---|---|
| Hydrocodone | Opioid analgesic |
| Aspirin | NSAID |
| Clinical data | |
| Trade names | Alor 5/500, Azdone, Damason-P, Lortab ASA, Panasal 5/500 |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
Hydrocodone/aspirin (INNs) is an oral combination drug formulation of the opioid analgesic hydrocodone and the nonsteroidal anti-inflammatory drug (NSAID) aspirin that is used in the treatment of chronic and acute pain.[1] It is sold under brand names including Alor 5/500, Azdone, Damason-P, Lortab ASA, and Panasal 5/500.
Adverse effects
See also: Aspirin § Adverse effects, and Hydrocodone § Adverse effects
See also
References
- ↑ Odom-Forren J, Drain C (11 February 2008). PeriAnesthesia Nursing: A Critical Care Approach. Elsevier Health Sciences. pp. 751–. ISBN 978-1-4377-2610-7.
Opioid receptor modulators | |
|---|---|
| MOR |
|
| DOR |
|
| KOR |
|
| NOP |
|
| Unsorted |
|
| Others |
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.